STAT Plus A richly funded CRISPR alternative has a reproducibility problem

STAT Plus: A richly funded CRISPR alternative has a reproducibility problem

12:01 EDT 26 Jul 2019 | STAT

USC scientists could not replicate the efficient genome editing previously reported by Homology Medicines.